Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 81.43% is in line with its 5-year average of 84.52%, around the middle of its 5-year range (78.65%–87.00%).
As of the fiscal period ended Tuesday, March 31, 2026. 3.68% below its 12-month average of 84.55%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
81.43%
GROSS MARGIN AVG TTM
84.55%
GROSS MARGIN AVG 3Y
84.55%
GROSS MARGIN AVG 5Y
84.81%
GROSS MARGIN AVG 10Y
86.59%
GROSS MARGIN AVG 15Y
88.94%
GROSS MARGIN AVG 20Y
91.01%
CURRENT VS TTM AVG
-3.68%
CURRENT VS 3Y AVG
-3.69%
CURRENT VS 5Y AVG
-3.98%
CURRENT VS 10Y AVG
-5.96%
CURRENT VS 15Y AVG
-8.44%
CURRENT VS 20Y AVG
-10.52%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+39.18%
vs the sector median at left
Regeneron Pharmaceuticals, Inc.
Market Cap
$67.58B
Gross Margin
81.43%
TTM Avg
84.55%
3Y Avg
84.55%
5Y Avg
84.81%
Market Cap
$65.77B
Gross Margin
70.41%
TTM Avg
65.16%
3Y Avg
63.29%
5Y Avg
62.03%
Market Cap
$56.65B
Gross Margin
46.48%
TTM Avg
45.33%
3Y Avg
44.44%
5Y Avg
44.19%
Market Cap
$81.91B
Gross Margin
25.56%
TTM Avg
26.70%
3Y Avg
26.59%
5Y Avg
26.68%
Market Cap
$84.78B
Gross Margin
34.92%
TTM Avg
41.06%
3Y Avg
39.99%
5Y Avg
47.00%
Market Cap
$47.58B
Gross Margin
78.01%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $67.58B | 81.43% | 84.55% | 84.55% | 84.81% |
| Boston Scientific Corporation (BSX)vs › | $65.77B | 70.41% | 65.16% | 63.29% | 62.03% |
| Cencora, Inc. (COR)vs › | $60.29B | 3.47% | 3.06% | 3.07% | 2.95% |
| Cigna Corporation (CI)vs › | $76.60B | 9.30% | 9.98% | 11.47% | 12.36% |
| Becton, Dickinson and Company (BDX)vs › | $56.65B | 46.48% | 45.33% | 44.44% | 44.19% |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 3.68% | 3.47% | 3.47% | 3.76% |
| Elevance Health Inc. (ELV)vs › | $81.91B | 25.56% | 26.70% | 26.59% | 26.68% |
| HCA Healthcare, Inc. (HCA)vs › | $84.78B | 34.92% | 41.06% | 39.99% | 47.00% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 78.01% | 78.79% | 78.80% | 77.78% |
| Humana Inc. (HUM)vs › | $46.74B | 14.01% | 14.54% | 16.14% | 17.03% |
Gross Margin
81.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 81.43% |
| 2025-12-31 | 84.95% |
| 2025-09-30 | 86.11% |
| 2025-06-30 | 85.58% |
| 2025-03-31 | 84.67% |
| 2024-12-31 | 85.08% |
| 2024-09-30 | 86.80% |
| 2024-06-30 | 86.46% |
| 2024-03-31 | 86.21% |
| 2023-12-31 | 81.68% |
| 2023-09-30 | 83.89% |
| 2023-06-30 | 83.91% |
| 2023-03-31 | 82.39% |
| 2022-12-31 | 85.15% |
| 2022-09-30 | 86.02% |
| 2022-06-30 | 87.00% |
| 2022-03-31 | 83.84% |
| 2021-12-31 | 78.65% |
| 2021-09-30 | 84.75% |
| 2021-06-30 | 85.12% |
| 2021-03-31 | 85.15% |
| 2020-12-31 | 82.88% |
| 2020-09-30 | 85.47% |
| 2020-06-30 | 82.87% |
| 2020-03-31 | 85.05% |
| 2019-12-31 | 85.19% |
| 2019-09-30 | 84.03% |
| 2019-06-30 | 87.46% |
| 2019-03-31 | 83.75% |
| 2018-12-31 | 91.70% |
| 2018-09-30 | 91.23% |
| 2018-06-30 | 92.21% |
| 2018-03-31 | 89.99% |
| 2017-12-31 | 91.14% |
| 2017-09-30 | 90.54% |
| 2017-06-30 | 90.61% |
| 2017-03-31 | 90.73% |
| 2016-12-31 | 91.56% |
| 2016-09-30 | 94.09% |
| 2016-06-30 | 94.31% |
| 2016-03-31 | 90.69% |
| 2015-12-31 | 89.91% |
| 2015-09-30 | 90.41% |
| 2015-06-30 | 91.10% |
| 2015-03-31 | 90.35% |
| 2014-12-31 | 92.59% |
| 2014-09-30 | 92.34% |
| 2014-06-30 | 93.03% |
| 2014-03-31 | 93.04% |
| 2013-12-31 | 92.12% |
| 2013-09-30 | 93.54% |
| 2013-06-30 | 91.34% |
| 2013-03-31 | 93.39% |
| 2012-12-31 | 92.72% |
| 2012-09-30 | 95.29% |
| 2012-06-30 | 92.82% |
| 2012-03-31 | 94.69% |
| 2011-12-31 | 97.57% |
| 2011-09-30 | 99.56% |
| 2011-06-30 | 99.63% |
| 2011-03-31 | 99.66% |
| 2010-12-31 | 99.55% |
| 2010-09-30 | 99.65% |
| 2010-06-30 | 99.65% |
| 2010-03-31 | 99.31% |
| 2009-12-31 | 99.60% |
| 2009-09-30 | 99.60% |
| 2009-06-30 | 99.52% |
| 2009-03-31 | 99.48% |
| 2008-12-31 | 98.87% |
| 2008-09-30 | 99.55% |
| 2008-06-30 | 99.99% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 95.84% |
| 2006-09-30 | 80.45% |
| 2006-06-30 | 85.41% |
| 2006-03-31 | 89.83% |
| 2005-12-31 | 87.69% |
| 2005-09-30 | 79.96% |
| 2005-06-30 | 89.77% |
| 2005-03-31 | 84.63% |
| 2004-12-31 | 92.62% |
| 2004-09-30 | 75.39% |
| 2004-06-30 | 98.14% |
| 2004-03-31 | 96.41% |
| 2003-12-31 | 95.74% |
| 2003-09-30 | 72.15% |
| 2003-06-30 | 97.54% |
| 2003-03-31 | 93.43% |
| 2002-12-31 | 64.86% |
| 2002-09-30 | 75.07% |
| 2002-06-30 | 66.58% |
